3rd Quarter - Report

ALEXION PHARMACEUTICALS, INC. for ALEXION PHARMACEUTICALS, INC.

Firm
Client
Income
—
Expenses
$350,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Camp Draft on tax reform Rep. Schwartz Patent Box draft Sen. Feinstein Patent Box draft

LobbyistCovered position, as disclosed
VANESSA PROCTER —
HEIDI L WAGNER —

Contacted: U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Food and Drug Administration Safety and Innovation Act (S. 3187) 2013 sequestration issues

LobbyistCovered position, as disclosed
VANESSA PROCTER —
HEIDI L WAGNER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; U.S. Trade Representative (USTR)

Bills named: S. 3187 (112th)

Trade (domestic/foreign) TRD

Korea-US Free Trade Agreement implementation

LobbyistCovered position, as disclosed
HEIDI L WAGNER —

Contacted: U.S. Trade Representative (USTR); SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.